{
    "title": "Individual feed for https://www.medscape.com/cx/rssfeeds/2700.xml",
    "link": "https://www.medscape.com/cx/rssfeeds/2700.xml",
    "description": "Individual feed output.",
    "lastBuildDate": "2025-11-03T16:35:19.764988",
    "items": [
        {
            "title": "Women Less Likely to Receive Heart Transplant",
            "link": "https://www.medscape.com/viewarticle/women-less-likely-receive-heart-transplant-yet-achieve-2025a1000u7v?src=rss",
            "description": "Medscape Medical News",
            "pubDate": "2025-11-03T20:32:55",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture9.png"
        },
        {
            "title": "Sweeteners Transform Both Weight Loss and Gut Health",
            "link": "https://www.medscape.com/viewarticle/sweeteners-transform-both-weight-loss-and-gut-health-2025a1000u7f?src=rss",
            "description": "Replacing sugars with sweeteners and sweetness enhancers supported weight loss maintenance and improved gut microbiota composition in adults with over...",
            "pubDate": "2025-11-03T18:44:10",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture5.png"
        },
        {
            "title": "UK Regulator Targets Delays in Rare Disease Treatments",
            "link": "https://www.medscape.com/viewarticle/uk-regulator-targets-delays-rare-disease-treatments-2025a1000u74?src=rss",
            "description": "The MHRA plans a flexible new framework to speed up access to treatments for rare diseases, addressing long delays and complex regulatory hurdles. Med...",
            "pubDate": "2025-11-03T17:36:38",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture6.png"
        },
        {
            "title": "Self-Injected Med Shows Rapid, Sustained Benefit in gMG",
            "link": "https://www.medscape.com/viewarticle/self-administered-med-shows-rapid-benefit-mg-2025a1000u5x?src=rss",
            "description": "Topline phase 3 results show that the novel nanobody gefurulimab is safe and effective for AChR-antibody-positive myasthenia gravis, but long-term res...",
            "pubDate": "2025-11-03T15:16:42",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture10.png"
        },
        {
            "title": "Systemic Therapy for Sj√∂gren Closer With Phase 3 Success",
            "link": "https://www.medscape.com/viewarticle/systemic-treatment-sj%C3%B6gren-disease-closer-successful-2025a1000u37?src=rss",
            "description": "Current treatment options have been limited to symptom control. Telitacicept, a novel fusion protein, and ianalumab, a monoclonal antibody, demonstrat...",
            "pubDate": "2025-11-03T13:24:19",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture9.png"
        }
    ]
}